Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent ...
When the standard malaria medications failed to help 18 critically ill patients, the attending physician in a Congo clinic acted under the 'compassionate use' doctrine and prescribed a ...
The Max Planck Institute of Colloids and Interfaces, Potsdam (Germany) will collaborate with ArtemiLife Inc., a US based company and medical researchers in Denmark and Germany to test Artemisia annua ...
CHENNAI: At a time when the farmers are protesting demanding waiver of loans, and some allegedly committing suicide, losing hope on agriculture as sustainable livelihood, a veteran farmer from Hosur, ...
Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the ongoing coronavirus disease 2019 (COVID-19) pandemic has led to over 121.2 million cases and over 2.6 million deaths ...
Artemisinin is a sesquiterpene lactone that has revolutionised the approach to malaria treatment. Produced in the specialised glandular trichomes of Artemisia annua, its biosynthesis is a multi‐step ...
Artemisia annua extract is being classified as a prescription medicine from today, following a recommendation from the Medicines Classification Committee (MCC). The new classification means it will no ...
The anti-breast-cancer drug has been produced from Artemisia annua plant and analyzed at laboratorial scale, and it has successful effects in reducing the size of breast cancer tumors in animal ...
Artemisinin (qinghaosu), a sesquiterpenoid lactone peroxide constituent of annual wormwood (Artemisia annua L. # ARTAN) that is used as an antimalarial drug, was tested for phytotoxic properties. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results